Navigation Links
Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA
Date:10/6/2008

NEW JERSEY, Oct. 6 /PRNewswire/ -- The organizers of Informex are delighted to announce their inaugural conference on Global Sourcing for the Pharmaceutical Industry, taking place November 10th-11th 2008 at the Princeton Marriott in New Jersey USA.

The conference is chaired by David Kinnear, President & CEO of the Global Sourcing Council, and boasts an unparalleled panel of key industry speakers including the likes of Johnson & Johnson, Bristol Myers Squibb, Genentech, Boehringer Ingelheim, and Roche Molecular Diagnostics.

Kinnear explains that there is no doubt that the evolution from early-day outsourcing to the more modern-day concept of global sourcing has led to some of the most profound fiscal and socio-economic implications of our century. The next generation of operational and business opportunity is one that no-one working in the field of pharmaceutical procurement can afford to ignore.

However, there is a real sense that whilst the opportunities presented by global sourcing are plentiful, the challenges are very real and need careful consideration if procurement professionals are to reap the rewards of a global sourcing strategy.

Issues addressed during the course of the two days include; applying the market and regulatory trends of the future to pharma's mid- to long-term strategy; transforming procurement organizations to respond quickly to the pressures of modern-day sourcing; implementing effective risk and governance strategies when dealing with emerging markets; identifying and initiating long-term supplier relationships in the most timely and cost-effective way; and adopting a sustainable approach to remaining informed about the latest low-cost country hotspots.

Delegates will benefit from a range of in-depth case study led presentations, interactive panel sessions, and country specific roundtables, as well as a networking drinks reception on the evening of Monday 10th November 2008.

For further infor
'/>"/>

SOURCE Informex
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
3. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
4. Briefing on a new Web resource to address global drinking water crisis
5. MDS Pharma Services Wins Award for Management of Global Malaria Trial
6. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
7. Resonant Medical Appoints New Vice President of Global Sales
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
10. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
11. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...DWOOD CITY, Calif., Jan. 8 /PRNewswire-FirstCall/ ...nnounced the appointment of Kimberly J. Popovits a...d chief operating officer,Popovits is now the pr....,Bradley Cole has been appointed as chief operat...pany,s chief financial officer, reporting to Popov...
(Date:1/8/2009)...RT LAUDERDALE, Fla., Jan. 8 The Si...rg ) today announced its creation of the Silver,S...to easily determine safe,usage levels of any diet...ed,to as ionic silver or colloidal silver. , ...-SilverSafety_72dpi.jpg) , *(Photo Caption:...
(Date:1/8/2009)...O, Jan. 8 /PRNewswire-FirstCall/ - MDS Inc. (TSX: ... and services to the global life sciences markets,...ollowing the completion of its year-end audit for ...y announced, for the fourth quarter 2008, MDS repo...e of the MDS Pharma Services goodwill write-down, ...
(Date:1/8/2009)...l Device Veteran David Bruce Joins as President an..., Jan. 8 Patient Safety ...unced that David Bruce has joined the company as i...also join its Board of Directors. Bill Adams, the ...in involved with the company as a consultant. , ...
Breaking Medicine News(10 mins):Health News:Genomic Health Announces Management Changes and New Responsibilities 2Health News:Genomic Health Announces Management Changes and New Responsibilities 3Health News:Genomic Health Announces Management Changes and New Responsibilities 4Health News:Silver Safety Pyramid Provides Guidelines for Safe Usage of Any Ionic Silver or Colloidal Silver Supplement 2Health News:Silver Safety Pyramid Provides Guidelines for Safe Usage of Any Ionic Silver or Colloidal Silver Supplement 3Health News:MDS Reports Final Fourth-Quarter 2008 Results 2Health News:MDS Reports Final Fourth-Quarter 2008 Results 3Health News:MDS Reports Final Fourth-Quarter 2008 Results 4Health News:Patient Safety Technologies Announces Expansion of Senior Management Team 2
...us form of skin cancer that accounts for more than...ts about its causes and characteristics could save...ome common myths about melanoma could help more pe...nd be more aware of melanomas that dont fit the ty...
...he growing epidemic of diabetes in the US is out. ...nd bounds . According to a drug trend report rele...atments trailed only cholesterol medications in to...g growth in 2006. An aging population and the ala...
...ble to identify neural signatures of effective, re...cord, measure and analyze both behavior and brain.... Researchers used a specially designed dual-elect...tual framework and methods of coordination dynamic...
...rio Cancer Institute at Princess Margaret Hospital...can be killed by a new cancer drug that is trigge...mic therapy (PDT). In a study published today in...demy of Sciences (PNAS), Dr. Gang Zheng, Senior Sc...
Other Medicine News:Health News:Myths About Melanoma Could Lead to Delayed Diagnosis and Treatment 2Health News:Myths About Melanoma Could Lead to Delayed Diagnosis and Treatment 3Health News:Myths About Melanoma Could Lead to Delayed Diagnosis and Treatment 4Health News:Spending on Diabetes Drugs Soars in US 2Health News:New Brain Neuromarker May Shed Light on Autism and Schizophrenia 2Health News:New Brain Neuromarker May Shed Light on Autism and Schizophrenia 3Health News:Scientists Activate New Cancer Drug Using Light and Oxygen 2
(Date:1/8/2009)...and Validate Novel Gene Expression Biomarkers Invo...ion Platform , , FREMONT, Calif., Jan. 8 /PRNew... Bulletin Board: WGBS), a leading developer of sta...ology and stem cell research systems, today announ...he University of Texas Southwestern Medical Cente...
(Date:1/7/2009)...wswire-USNewswire/ -- Scientists have identified m...of relapse in children with acute lymphoblastic le...t further research is needed to determine how chan...to leukemia relapse, the findings are likely to pr...ess the risk of treatment failure. By using a mole...
(Date:1/7/2009)... 7 Circassia Ltd, a specialty,bio...ical care, today,announced that following success...leroMune(R) anti-allergy technology, the company h...r phase II clinical trial in cat allergy. The,stu... patients with confirmed,cat allergies, and all t...
(Date:1/6/2009)...wswire-USNewswire/ -- Sequella, Inc., a clinical-s... of epidemic potential, announced today that SQ109...erculosis (TB), was the first drug approved for ev...act to Dynport Vaccine Company LLC and Quintiles T...l Institute of Allergy and Infectious Diseases (NI...
Breaking Medicine Technology:WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3SafeHands School Program to Help Fight Spread of MRSA Staph Virus 4583 1SafeHands School Program to Help Fight Spread of MRSA Staph Virus 4583 2Cowen Group Inc and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team 1500 1Cowen Group Inc and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team 1500 2Cowen Group Inc and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team 1500 3Research Study Demonstrates Prolonged Benefit of Fitness Program for Bladder Control 26 Sexual Function in Women 657 1Research Study Demonstrates Prolonged Benefit of Fitness Program for Bladder Control 26 Sexual Function in Women 657 2Research Study Demonstrates Prolonged Benefit of Fitness Program for Bladder Control 26 Sexual Function in Women 657 3Frog study takes leaf out of natures book 965 1Frog study takes leaf out of natures book 965 2
...I PHARMA, INC.,(NASDAQ:MOGN), a biopharmaceutical ...announced the presentation of results of a,success...ol,disodium) Injection in patients undergoing colo...esults, as well as safety data, were,presented at ...,Lawrence B. Cohen, MD, Department of Medicine/ Ga...
...rine Flow, With,Long Lasting Effect in Phase 2 Stu...Call/ -- Spectrum,Pharmaceuticals, Inc., today ann...ix, the Company,s drug candidate for the treatment...rican Urology,Association Annual Meeting held at t...a on Tuesday, May 22, 2007. , "The results of this...
Other Medicine Technology:Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 2Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 3Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 4Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 5Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 2Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 3Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 5
Titanium. Curved shafts with 5.5 mm tying platform. Round knurled handle with dull finish. Overall length 4.3 inches.
Ultra-fine 5 mm tying platform is valuable when manipulating delicate 10-0 and 11-0 sutures. Pin in handle keeps tips in alignment. Shafts available straight or angled 45 degrees, 8 mm from tip. Stra
Angled 45 degree shafts with tying platform. Wide serrated handle with dull finish. Overall length 4.2 inches.
Ultra-fine tying platform with round knurled handle for fingertip rotational control. Curved shafts. Overall length 3.9 inches.
Medicine Products: